Suppr超能文献

经皮透视引导下放置腹膜透析导管——10年经验

Percutaneous fluoroscopically guided placement of peritoneal dialysis catheters--a 10-year experience.

作者信息

Vaux Emma C, Torrie Peter H, Barker Lindsey C, Naik Ramesh B, Gibson Matthew R

机构信息

Department of Renal Medicine, Royal Berkshire Hospital, Reading, Berkshire, UK.

出版信息

Semin Dial. 2008 Sep-Oct;21(5):459-65. doi: 10.1111/j.1525-139X.2008.00463.x. Epub 2008 Aug 29.

Abstract

Peritoneal dialysis (PD) catheters maybe inserted surgically or percutaneously. Since 1997, 209 patients in our unit have had a PD catheter inserted percutaneously with fluoroscopic guidance. Data on all these PD catheters were collected prospectively on a PROTON computer database. 5/209 (2.4%) insertion attempts were abandoned. 204 catheters were successfully placed giving an initial technical success of 97.6%. 200/204 catheters were used for dialysis. 13/200 (6.5%) catheters developed early exit site infections; 12/13 were successfully treated and dialysis proceeded uneventfully. 3/200 (1.5%) catheters developed early peritonitis; 1/3 was removed as antibiotic treatment was unsuccessful. 10/200 (5%) catheters developed an early leak; 2/10 did not resolve with conservative therapy and were removed. 14/200 (7%) catheters did not allow sufficient fluid entry for PD; all 14 had migrated out of the pelvis and were removed. In total, 18/200 (9%) catheters were removed in the first 2 months due to these early complications. The remaining 182/200 (91%) were fully functional for PD. Technical survival (excluding patient death with a functioning catheter and successful kidney transplantation) at 1, 2, and 5 years was 77%, 61%, and 31%, respectively. Our 10 year experience of PD catheters inserted percutaneously with fluoroscopic guidance demonstrates a high technical success and a low complication rate. The data presented may be used as the standard for this technique.

摘要

腹膜透析(PD)导管可通过手术或经皮插入。自1997年以来,我们科室有209例患者在透视引导下经皮插入了PD导管。所有这些PD导管的数据均前瞻性地收集在一个PROTON计算机数据库中。209次插入尝试中有5次(2.4%)被放弃。204根导管成功置入,初始技术成功率为97.6%。204根导管中有200根用于透析。200根导管中有13根(6.5%)发生了早期出口部位感染;其中12根成功治愈,透析顺利进行。200根导管中有3根(1.5%)发生了早期腹膜炎;其中1根因抗生素治疗失败而被拔除。200根导管中有10根(5%)发生了早期渗漏;其中2根经保守治疗未缓解而被拔除。200根导管中有14根(7%)无法使足够的液体进入以进行PD;所有14根均已移出盆腔并被拔除。由于这些早期并发症,200根导管中有18根(9%)在最初2个月内被拔除。其余182根(91%)可完全用于PD。1年、2年和5年的技术生存率(不包括导管功能正常且肾移植成功的患者死亡)分别为77%、61%和31%。我们在透视引导下经皮插入PD导管的10年经验表明技术成功率高且并发症发生率低。所呈现的数据可作为该技术的标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验